跳转至内容

主要文件

查看所有文档

I-028

Interference Mix 6

5-100 μg/mL each component in methanol, Cerilliant®

别名:

Qualitative Interference Mixture

登录并加购，请在购物车里查看协议价、货期和发货地。

选择规格

变更视图

关于此项目

NACRES:
NA.24
UNSPSC Code:
41116107
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

grade

analytical standard

Quality Segment

form

liquid

composition

Amlodipine besylate, 5 μg/mL (as free base), Atorvastatin calcium salt, 100 μg/mL (as free base), Azithromycin dihydrate, 100 μg/mL (as free base), Bupivacaine hydrochloride monohydrate, 100 μg/mL (as free base), Cetirizine dihydrochloride, 50 μg/mL (as free base), Dimenhydrinate, 100 μg/mL , Lisinopril dihydrate, 100 μg/mL (as free base), Loratadine, 100 μg/mL

packaging

ampule of 1 mL

manufacturer/tradename

Cerilliant®

concentration

5-100 μg/mL each component in methanol

technique(s)

gas chromatography (GC): suitable, liquid chromatography (LC): suitable

application(s)

forensics and toxicology

format

single component solution

storage temp.

−20°C

General description

A multi-component solution standard of routinely monitored over-the-counter (OTC) and prescription drugs amlodipine, atorvastatin, cetirizine, azithromycin, bupivacaine, dimenhydrinate, lisinopril, and loratidine. This standard is for qualitative use only in the evaluation of interferences between the mix components and target analytes of interest in a testing laboratory′s analytical methods.

Legal Information

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

警示词

Danger

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

靶器官

Eyes,Central nervous system

存储类别

3 - Flammable liquids

怎么回事？

WGK 2

闪点 (F)

49.5 °F - closed cup

闪点 (°C)

9.7 °C - closed cup

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库